PK72
PHAR BUS MACY ACA INESS DEM Y
THE PHARMACY SHOW IN NUMBERS
PJ70
HOLD
PJ72
PJ70
S
REAL WORLD
PJ62
RETAIL
PH70
PJ22
PH72
PINDERS
PH60
PF68
RAPEED PJ60
K R FINANC
AEPC
WELOCUM PJ65
LATEST 2017 FLOORPLAN & EXHIBITOR LIST
PG70
HOLD
PG76
IALPLANNING
PH61
ECOVAPE
PH63
PG71
BSK MEDICA PG73 L
PG75
PK55
KEYN OTE THEA TRE
SILVER LEVENE
DAY LEWIS
PJ50
PJ31
PHARMA SUPPORT CIST
PK26
PH30
PJ32
MEDICARE
EPOS LOGIC
CST PHARM
PK25
SHAWBROOK
PH35
IPS
PH31
A
KENT PHARM
PJ19
A
TOLIFE
SEE PAGE 6
COSMEBEL
FARMENA
SPECIALS LAB OCCLES
PH15
PJ17
PJ12
PJ59
SHOPRX
SEE PAGES 12 & 13
ARJUN PJ14 OXFORD PRODUCTS PHARMA STORE NHSCY
HEALTH AID
PJ1
RA ACCOUN TANTS PJ3
EDUCATION HUB
PJ5
WISDOM TOOTHB RUSHES
PROMPT IT
PREMIER HEALTH
PRODUCTS
PH01
HEALTH CHECK
SERVICES
RIPSNORE PROFOOT
PG11
PG11A
CAFLON
COMVITA PG20 LOGIXX PHARM PG17
PG03
PG12
LLOYDS BANK
NOVA MEDICA
PF01
PF12
PHARMA MEDICO
ROBOSOL PIVOTELL
PF14 PF16
BBI HEALTH
PE18 IMMUTES
CARE
PE10 PE14
AKL
PF1
APPROVE SHOPFITTIND G
PC54
THE MEDICA PC55 INSURANCE L ADVISORY BUREAU LTD. PHARMA
DENWARD MANUFACTURI NG
PE20 PE16 MEDISCA
MEDIWIN T PE17 PE19 S&J PHARMACY INTERNATIONAL SOLUTIONS PE11 GLOBAL 1ST PE12 SYNERG SHORELINE BRG INC. IE MÉDICALE PE01
PB71
SCOPE OPTHALMICS
ACDOCCO
PB75 PD72
PB74
HRA & IRE
PUB & WE LIC HEA LTH LLBEIN G FOR U
PB50 PB58
THEA PHARM
PB55
NORD
UHY
GP
PFIZER
PC30
RPS
PRACTI PHARM CE AC HUB Y
PB30
ROBOTIK TECHNO
LOGY
PC22 PC20
ROBOPHARMA
PD21 PC25
LTD.
PD10
PA3 PB20
B.V.
FR PA25
ECG TRAINI LTD. NG
WILLACH
PA22
CHIESI
PC11
PA20
PC12
OMNICELL
SPLAT
PC10
FORTUNA HEALTHC ARE
NATURA ORGANI L INC. CS
PB10 PB12
FREZYDERM
PD5
BD ROWA TECHNO
PA15
LOGIES
STADN
PA12
LEOSONS
LABCOLD
PA10
ROYAL BRUSH
VIS ENTRITOR ANC E
THE SPOTLIGHT IS ON PHARMACY. don’t BE left in the dark...
B U TC H E R
@pharmacyshow
The Pharmacy Show Network
Winter newspaper - February 2017
NPA DUTY IS TO LEAD INDEPENDENTS ALONG A ROAD BUILT ON SOLID FOUNDATIONS
QUALITY PAYMENTS SCHEME – WHAT PHARMACY CONTRACTORS NEED TO DO
It is now over a year since NHS England and the Department of Health issued their prospectus for severing the link between services and medicines supply. It has been necessary – and continues to be necessary - to push back hard against that flawed concept. Down that road lies a de-professionalized local service, a demoralized workforce, and ultimately a fractured community pharmacy network.
On 20th October 2016, the Government imposed a twoyear funding package on community pharmacy; this included a Quality Payments Scheme.
Written by Ian Strachan, Chair, NPA.
For pharmacies to prosper, the historic link between medicines supply and pharmacy premises must be maintained. This link is a crucial element of an established, trusted service model in community pharmacy – namely convenient, face-to-face care from health care professionals, locally responsive and community based. In turn, the sustainability of this model requires that supply and professional service complement one another and are not separated. As independents, the link between supply and service is our history and our future, wherever we operate in the UK. The real danger from the current Department of Health approach to the sector is that it could pull these elements apart – separating supply from service and in so doing breaking the premises based, contractor model that has served so many patients so well for so long. Ian Strachan
This month’s publication by Pharmacy Voice and PSNC of the Community Pharmacy Forward View: Making It Happen points to a better way. We earnestly hope that the movers and shakers in Government will seize this opportunity to change direction. At the time of writing, we still await an official response to the Murray Review of Clinical Services. NHS England’s response will be one test of their willingness to think differently. I believe the NPA is duty-bound to maintain the integrity of the community pharmacy network, and to lead independents through change, to a strong, sustainable position at the heart of the NHS. Our task is not to look backwards for a golden age, it is to lead independents towards a better future. Yet this journey must be along a road built on solid foundations – not the slippery path laid out for pharmacy by the Department of Health.
The NPA has served independents for nearly 100 years and we intend to help the sector adapt and thrive for generations to come. Yet we cannot do this in isolation. That is one reason why we have called on colleagues across the community pharmacy sector to more clearly align strategy with formal negotiation of the contractual framework. Pharmacy’s leadership structures must be fit for purpose in the time ahead – capable of defining and describing what a sustainable, long term future looks like, persuading government and NHS to back the changes needed and supporting pharmacies to meet the challenge of continuing improvement and consistent delivery of excellent care. The campaign against Government proposals to cut pharmacy funding and related ‘efficiencies’ shows that the sector is capable of working closely together and presenting a united front. Working together to oppose changes we don’t like is one thing. Working together to advance the fundamental changes that we do
Continued on p4
Some details relating to the Quality Payments Scheme still need to be clarified by NHS England; as further information becomes available, PSNC will include this on the Quality Payments Scheme hub of the PSNC website (psnc.org.uk/quality). The scheme is voluntary – contractors do not need to engage with it – but PSNC recommends that contractors should seek to meet as many of the quality payments criteria as possible. Contractors that successfully meet the requirements will receive payments from a £75 million budget that is part of the overall community pharmacy funding budget of £2.592 billion. Gateway criteria To qualify for payments related to meeting the quality criteria, contractors must also meet four gateway criteria on the day of the review; passing the gateway criteria will not itself earn any payment for the contractor: 1) the contractor must be offering at the pharmacy Medicines Use Reviews (MURs) or the New Medicine Service (NMS) or must be registered to provide the NHS Urgent Medicine Supply Advanced Service (NUMSAS); 2) the NHS Choices entry for the pharmacy must be up to date; 3) pharmacy staff at the pharmacy must be able to send and receive NHS mail; and 4) the contractor must be able to demonstrate ongoing utilisation of the Electronic Prescription Service (EPS) at the pharmacy premises.
Continued on p2
Register your interest now at www.thepharmacyshow.co.uk/newspaper Media partners
Supported by
Charity partner
LTD
PB40
VMI CARE PB45
RPS THEA TRE
DIVA PD3 INTERNATIONAL SWEDSAFE PD01 AB
www.thepharmacyshow.co.uk
ACUTICALS
PB59
PC40
PC31
L SOLUTIONS
ALTACOR
TIANA PF9
PD20
PE15
PF10
CARE
THE PHARMA CONSULTANCYCY PF3 DOMETIC PF5 ROCK TAPE PF8 LUBRISYN HA
CARE LTD.
ASSOCIATION
PD22
MARTIN PHARMADALE LTD.
PB70
NHS HEALTH EDUCATI ENGLANDON
PC41
PHARMACY
HOLD
VIP LOUN GE
A. VOGEL
HONEY ROSE
PG18 UNIVERS BRADFORDITY OF NORTHWEST HEALTH
BRANDS
EMT HEALTH
CHRISTIE +CO
PD35
HOLD
HOLD PF18
NHS DIGITAL
LTD.
PC52
PD30
SIGMA
PF15
A
MICROLIFE HEALTH PG19 MANAGEMENT A&D INSTRUM ENTS
NATIONAL
SALUS (UK)
CENTRE PHARMA FOR POSTGRACY PB20 EDUCATIONDUATE
PC68
ERS
PC50
PD52
PD40
CLOVER 51
LICE SNATCH
PC65
IDIS
PF20
O’KEEFE’S
PG15A
ON CALL PG14 DURBIN BRAY GROUP PG16
PG10
BOOT CAMP
PG01
PD45
YOU
PF29
PF26 PG15 PG13
PH18
SWAINE INTERNA S PH10 TIONAL
PE40
PC73
BIOPATHICA PC66
SKINS SEXUAL HEALTH
GLEN DIMPLE PB50 PROFES X LTD. SIONAL APPLIANCES
ECOGEN EUROPE
OMRON
PF28
PC60
JEI DANIEL BIOTECH CORP
PC72
MPUA
PD53
RAYNER PHARMACEUTI CALS
PC79
PC75
PD66
LTD.
CITY SPRINT HEALTHCARE
CAFÉ
PC70
PD74
PD58
PE30
RBUK PF32
PH17
PH13
PH14 QUEENS BELFAST UNIVERSITY
PH11
CAFÉ
NT &
PD75
PD73
ENOCH EVANS
ORDERWISE
BY
NICOCIGS
PH16
APTUK LABORA PH16A DUDLEY HUNT PH18A LISANDRATOIRE BERLINGER PH18 & CO. SCIENCE OF SKIN
PJ13
PJ11
LEASE UK
PHAR MACY TECHNO LOGY SPON SORED
PG21
PJ18
CHIESI
PJ16
PK12
BPERFEC COSMETICTS
NAVIMED LTD.
PF35
ACY
PG20
PK15
PJ15
PD76 PD72
PD60
MOBILITY 2
PF30
WELL PHARM
PH20
RESOURC MEDICAL E
GPHC
PE46
AURA
PD70
VALNEVA UK
PH30
HOLD
PJ20
PK21
SCANLITE
REST
SALISBURY NHS FOUNDA PE70 TION TRUST COSTCO WHOLES ALE LTD. PE71 PE78 PE75 SUN PATCH PE79 EVE TAYLOR LTD. (LONDON) PE74 LTD.
PE49
PK20
CLIN THEAICAL TRE
PF70
VMD
PG77 PH68 ALUIM PF76 PG74 PENNIN PH62 TIPPING POINT PF72 PF78 MANCHESGTONS CLARIPHARM ARRA GROUP PH64 LABORATOIRE SYRINGA BSN MEDICA PJ59 VELRESCO PF74 MEDIHOLDINGS L PSN INADA MASSA PJ51 DOORSTOP GE CHAIRS PH57 PJ57 ROSKERR INNOV C PHAR GROSVENOR ATTENDS PHARMACY SCRIPT TV PJ58 ATION MACY DX NETWO PRIME FIFTY PF66 NCE SERVICES RK PH58 PG MUTUA PJ54A NICE-PAK INTERN &ABUNDA THEA PH58A L PH55A TRE ATIONAHEALTH PJ53 PH59 PF65 L PH52 PJ54 PF62 PG51 PDT HAZELW SOLI PG53 CITORS KAYS MEDICA STIMARE PF61 REGENT OODS HIMALAYA PHARMACE WEST AYMES PG59 L UTICALS PF64 PK40 PH54 BIO-LIFE HERBALS DAXXIN LAB PG53A INTERNATIO PH52 METHAMEASURE REGENT HBT NAL PJ40 PH56A PH51 AVANO PG55 PH50 THE PHARM R PF55 PG69A PH56 HEALTHCARE ACY WEBSIT PJ45 MAGNETICOS ARTDEC MEDEPOS E COMPANY PG52A LTD. ETHIGEN PF58 PHARMACIST-X O/MISSLYN PG54A PREMVAN LTD PH40 WOGEN PG58A RXWEB PG50 WAVE PG58 READYS PG50a PEX PG56 HOLD PF51 L’ERBOLARIO RUSHPORT PF52 PG40 BIO-FRESH I HUTCHINGS NTERNATIO CONSULTANTS NAL GSK LTD. PK30 MY FUNCTIO PJ30 PF40 AL RESEARCHN M+N HEALTH & BEAUTY PF48 LEXON PK28 PK50
PK10
SEE PAGE 4
ACCOUNTANT
M CUBED CHARLE RUSSELLS SPEECHLEY
SKIN SHOP
RPS’ CAMPAIGN ON LONG TERM CONDITIONS
MHRA
PK71 ROKSHAW PK70 ATS PK60 PK65
PB01
CAM RX
PB8